Ribosomal RNA evidence of ocular Chlamydia trachomatis infection following 3 annual mass azithromycin distributions in communities with highly prevalent trachoma
- PMID: 22095569
- PMCID: PMC3245728
- DOI: 10.1093/cid/cir791
Ribosomal RNA evidence of ocular Chlamydia trachomatis infection following 3 annual mass azithromycin distributions in communities with highly prevalent trachoma
Abstract
Twelve trachoma-hyperendemic communities were treated with 3 annual mass azithromycin distributions. Children aged 0-9 years were monitored 1 year following the third treatment. An RNA-based test detected ocular chlamydial infection in more children than did a DNA-based test (6.9% vs 4.2%), and in a larger number of communities (8 vs 7).
Trial registration: ClinicalTrials.gov NCT00322972.
References
-
- Solomon A, Zondervan M, Kuper H, Buchan J, Mabey D, Foster A. Trachoma control: a guide for programme managers. Geneva, Switzerland: World Health Organization; 2006.
-
- Bird M, Dawson CR, Schachter JS, et al. Does the diagnosis of trachoma adequately identify ocular chlamydial infection in trachoma-endemic areas? J Infect Dis. 2003;187:1669–73. - PubMed
-
- Ngondi J, Gebre T, Shargie EB, et al. Evaluation of three years of the SAFE strategy (Surgery, Antibiotics, Facial cleanliness and Environmental improvement) for trachoma control in five districts of Ethiopia hyperendemic for trachoma. Trans R Soc Trop Med Hyg. 2009;103:1001–10. - PubMed
-
- Mkocha H, Munoz B, West S. Trachoma and ocular Chlamydia trachomatis rates in children in trachoma-endemic communities enrolled for at least three years in the Tanzania National Trachoma Control Programme. Tanzan J Health Res. 2009;11:103–10. - PubMed